Trulicity (dulaglutide) is an injectable medicine prescribed to treat Type 2 Diabetes, in conjunction with diet and exercise. Trulicity is not insulin; instead, it works by acting like a specific hormone in the body (GLP-1) which naturally lowers the body’s blood sugar.
Although there are a variety of Diabetes drugs, and physicians have many options available for prescriptions, almost all of those drugs are expensive. In the past decade, the cost of diabetic medications in general keeps rising. When patients factor in the costs of syringes, glucose testing strips, and sharps containers, diabetic prescriptions add up quickly. A month’s supply of Trulicity alone can cost uninsured patients nearly $500.
To begin getting some relief, consumers can compare prices and start saving money at the pharmacy with a Trulicity coupon.
Manufacturer Coupons for Trulicity
Lilly, the makers of Trulicity, offer a Trulicity Savings Card online. For patients who qualify, the savings can be significant; Lilly pays the first $150 a month, depending on insurance, and some patients may pay as little as $25 per prescription (for the first 26 prescriptions).
Lilly also has a hotline to answer any patient questions regarding a Trulicity prescription or the Lilly’s Savings Card offer. The line is open M–F, 9–8 Eastern.
1-844-878-4636
Patient Assistance Programs for Trulicity
Lilly Cares is a patient assistance program where patients without insurance, or those with Medicare Part D, can apply for Trulicity prescription assistance. The Lilly Cares program can offer assistance with a list of medications in addition to Trulicity.
Medicare recipients may also qualify for additional governmental assistance on the costs of their prescriptions. Patients can check out the SSA’s Extra Help Program online to see if they qualify.
Note: The information provided in this article is for educational purposes only and should not be substituted for professional medical advice. Always consult with your healthcare provider for personalized guidance and treatment options.
Comments are closed.